Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Hoon | - |
dc.contributor.author | Bae, Jae Hyun | - |
dc.contributor.author | Oh, Cheol Young | - |
dc.contributor.author | Jeong, Seong Jin | - |
dc.contributor.author | Ko, Woo Jin | - |
dc.contributor.author | Choi, Jong Bo | - |
dc.contributor.author | Seo, Ju Tae | - |
dc.contributor.author | Lee, Dong Hwan | - |
dc.contributor.author | Kim, Joon Chul | - |
dc.contributor.author | Lee, Kwang Woo | - |
dc.contributor.author | Kim, Young Ho | - |
dc.date.accessioned | 2021-09-02T13:58:52Z | - |
dc.date.available | 2021-09-02T13:58:52Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-03 | - |
dc.identifier.issn | 2093-4777 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/76814 | - |
dc.description.abstract | Purpose: To compare the clinical efficacy of anticholinergics for managing diabetes mellitus-associated overactive bladder (DM OAB) versus idiopathic overactive bladder (OAB) in Korean women. Methods: We conducted a multicenter, prospective, parallel-group, open-label, 12-week study Women (20-65 years old) with OAB symptoms for over 3 months were assigned to the DM OAB and idiopathic OAB groups, Changes in the Overactive Bladder Symptom Score (OABSS), urgency, urinary urgency incontinence, nocturia, daytime frequency according to a voiding diary, uroflowmetry, and postvoid residual urine volume (PVR) at the first visit (V1), week 4 (V2), and week 12 (V3) were compared. Results: No significant difference was found between the baseline patient characteristics of the DM OAB and idiopathic OAB groups. Treatment with solifenacin was associated with improvements in urgency, urinary urgency incontinence, nocturia, frequency according to a voiding diary, and the total OABSS between V1 and V2 and between VI and V3. Moreover, a significant improvement in urgency and urge incontinence was found between V2 and V3 in the DM OAB group. However, no significant changes were found in any other parameters. There were no significant differences between the DM OAB group and the idiopathic OAB group except for urgency and urge incontinence at V2 (3,71 vs. 2.28 and 0.47 vs, 0,32, respectively). Conclusions: The patients who received solifenacin demonstrated improved urgency, urinary urgency incontinence, nocturia, frequency according to a voiding diary, and total OABSS, Management with solifenacin was equally effective for both DM-related OAB and idiopathic OAB. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN CONTINENCE SOC | - |
dc.subject | URINARY-TRACT SYMPTOMS | - |
dc.subject | RISK-FACTORS | - |
dc.subject | METABOLIC SYNDROME | - |
dc.subject | SMOOTH-MUSCLE | - |
dc.subject | PREVALENCE | - |
dc.subject | WOMEN | - |
dc.subject | POPULATION | - |
dc.subject | INCONTINENCE | - |
dc.subject | DYSFUNCTION | - |
dc.subject | CYSTOPATHY | - |
dc.title | Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Hoon | - |
dc.contributor.affiliatedAuthor | Bae, Jae Hyun | - |
dc.identifier.doi | 10.5213/inj.1834982.491 | - |
dc.identifier.scopusid | 2-s2.0-85046437196 | - |
dc.identifier.wosid | 000428953900007 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL NEUROUROLOGY JOURNAL, v.22, no.1, pp.51 - 57 | - |
dc.relation.isPartOf | INTERNATIONAL NEUROUROLOGY JOURNAL | - |
dc.citation.title | INTERNATIONAL NEUROUROLOGY JOURNAL | - |
dc.citation.volume | 22 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 51 | - |
dc.citation.endPage | 57 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002330361 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | URINARY-TRACT SYMPTOMS | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | METABOLIC SYNDROME | - |
dc.subject.keywordPlus | SMOOTH-MUSCLE | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | WOMEN | - |
dc.subject.keywordPlus | POPULATION | - |
dc.subject.keywordPlus | INCONTINENCE | - |
dc.subject.keywordPlus | DYSFUNCTION | - |
dc.subject.keywordPlus | CYSTOPATHY | - |
dc.subject.keywordAuthor | Anticholinergics | - |
dc.subject.keywordAuthor | Overactive urinary bladder | - |
dc.subject.keywordAuthor | Diabetes mellitus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.